Seres Therapeutics, Inc. (MCRB) › Weighted Average Diluted SharesSeres Therapeutics, Inc. (MCRB) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 79.79M2021-12-31: 91.70M2022-12-31: 108.08M2023-12-31: 6.40M2024-12-31: 7.77M2025-12-31: 8.87M8.87M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-318.87M+14.2%2026-03-12From 2025-01-012024-12-317.77M+21.4%2026-03-12From 2024-01-012023-12-316.40M-94.1%2026-03-12From 2023-01-012022-12-31108.08M+17.9%2025-03-13From 2022-01-012021-12-3191.70M+14.9%2024-03-05From 2021-01-012020-12-3179.79M—2023-03-07From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)